Medroxyprogesterone Acetate
Back to searchMolecule Structure
Scientific Name
Medroxyprogesterone Acetate
Description of the Drug
Medroxyprogesterone acetate is a progestin used as a contraceptive and in the treatment of secondary amenorrhea, abnormal uterine bleeding, pain from endometriosis, endometrial and renal carcinomas, paraphilia in males, and GnRH-dependent precocious puberty.
http://www.drugbank.ca/drugs/DB00603
Brand Name(s)
Adgyn medro, Amen, Climanor, Curretab, Cycrin, Depo-progevera, Depo-provera, Depo-provera oncology, Depo-subq provera 104, Farlutal, Farlutal 100, Farlutal 200, Farlutal 250, Farlutal 500, Lunelle, Medroxyprogesterone acetate, Provera, Sayana press
Company Owner(s)
Teva Pharmaceuticals Usa Inc, Cipla Ltd, Mylan Laboratories Ltd, Sandoz Inc, Sun Pharmaceutical Industries Ltd, Duramed Pharmaceuticals Inc Sub Barr Laboratories Inc, Esi Pharmacal, Upsher Smith Laboratories Llc, Eugia Pharma Specialities Ltd, Amphastar Pharmaceuticals Inc
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Progesterone receptor | SINGLE PROTEIN | AGONIST | CHEMBL208 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL4276 | |||
| DrugBank | DB00603 | |||
| PubChem: Thomson Pharma | 14853921 | 14780490 | ||
| PubChem | 6279 | |||
| LINCS | LSM-5882 | |||
| Nikkaji | J5.247G | |||
| BindingDB | 50067678 | |||
| EPA CompTox Dashboard | DTXSID0025527 | |||
| DrugCentral | 1659 | |||
| ChemicalBook | CB8130110 | |||
| rxnorm | MEDROXYPROGESTERONE ACETATE | PROVERA | MEDROXYPROGESTERONE | DEPO-PROVERA |
| KEGG Ligand | C08150 | |||
| ChEBI | 6716 | |||
| ZINC | ZINC000005029557 |
